FindTrial
Sign In

Clinical evaluation of rasna panchak kwath in aamvata with special references to changes in rhematoid factor - an open-label single-arm study

SINGLE ARM CLINICAL STUDY TO ASSESS THE UPASHYATMAK EFFECT OF RASNAPANCHAK KWATH IN AAMVATA W.S.R. TO RA FACTOR - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/107055
Enrollment
45
Registered
2026-03-30
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M218- Other specified acquired deformities of limbs

Interventions

None listed

Sponsors

DrMohit Vinod Dikondwar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subject having age between 20 to 60 years. Irrespective of gender, religion, marital status, socio-economic status and occupation. Patient having signs and symptoms Sandhishool (joint pain), Sandhistabdhata (joint stiffness), Sparshasahatva (tenderness), Sandhishotha (swelling), Jwara, Gaurav, Agnimandya 4) Known case of Rheumatoid Arthritis. 5) RA positive patient with value greater than 20 IU/ml, less than or equal to 80 IU/ml

Exclusion criteria

Exclusion criteria: Subject having known case of HIV, IHD, Heart defects, Chemotherapy, Diabetic mellitus. Age below 20 above 60 years. Patient with arthritis of other origin [osteoarthritis, ankylosing, spondylitis] Aamvata with updrav (trushna, chardhi, bhram, malavstambh, Antrakunjan, Aadhman) 5) Pregnant womens and lactating mothers.

Design outcomes

Primary

MeasureTime frame
Single arm clinical study to assess the upashayatmak effect of Rasnapanchak Kwath in Aamvata w.s.r to RA factor .Timepoint: Aproximately 3-4 months—

Secondary

MeasureTime frame
Nidanpanchak study of Aamvata.Timepoint:—

Countries

India

Contacts

Public ContactDrMohit Vinod Dikondwar

Yashwant Ayurvedic College and postgraduate training and research center Kodoli

mohitdikondwar35970@gmail.com9145697771

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026